Children’s Hospital Los Angeles Leads Development of First Machine Learning Tool to Predict Risk of Cisplatin-Induced Hearing Loss

Children’s Hospital Los Angeles Leads Development of First Machine Learning Tool to Predict Risk of Cisplatin-Induced Hearing Loss

LOS ANGELES--(BUSINESS WIRE)--May 7, 2025-

Children’s Hospital Los Angeles Develops First Machine Learning Tool to Predict Risk of Cisplatin-Induced Hearing Loss | Hearing Health & Technology Matters

LOS ANGELES, CALIFORNIA – An international research team led by Dr. Etan Orgel at Children’s Hospital Los Angeles (CHLA) has developed a machine learning model designed to estimate a child’s risk of developing hearing loss after receiving the chemotherapy drug cisplatin. The tool, known as PedsHEAR, was built using routinely available clinical information and has demonstrated 95% predictive accuracy. Results of the study were published in the Jo…